Isoda, Atsushi
Miyazawa, Yuri
Ishikawa, Tetsuya
Kanaya, Shuhei
Nakayama, Keita
Mihara, Masahiro
Iriuchishima, Hirono
Saito, Akio
Matsumoto, Morio
Sawamura, Morio
Article History
Received: 4 May 2022
Accepted: 25 August 2023
First Online: 1 September 2023
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. All study protocols were reviewed and approved by the ethics review board at Nishigunma Hospital (approval nos. 15-11-04, 16-01-03) and the study was registered to the University Hospital Medical Information Network Clinical Trials Registry (UMIN000042804).
: All participants provided written informed consent prior to participation.
: N/A.
: M. Matsumoto received an honorarium from Janssen Pharmaceutical and Sanofi K.K.